Latest & greatest articles for alzheimer's disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on alzheimer's disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on alzheimer's disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for alzheimer's disease

1. Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis Full Text available with Trip Pro

Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Neurosurg Psychiatry Actions . 2021 Feb;92(2):195-203. doi: 10.1136/jnnp-2020-323870. Epub 2020 Oct 28. Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis # , # , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Psychiatry and Center for Geriatric and Gerontology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. 2 Graduate Institute of Medicine, College

2021 EvidenceUpdates

2. Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis

Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information (...) to moderate Alzheimer's disease: systematic review and meta-analysis # , # , # , # , , , , , , , , Affiliations Expand Affiliations 1 Clinical Research and Data Center, South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China. 2 Department of Neurosurgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. 3 Department of Health Research Methods, Evidence,and Impact

2020 EvidenceUpdates

3. Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer disease and highlights potential translational opportunities Full Text available with Trip Pro

Biomèdiques August Pi i Sunyer , Barcelona, Spain 161 Alzheimer’s disease and other cognitive disorders Unit. Neurology Department , Hospital Clinic, Barcelona, Spain Laura Montrreal 9 Research Center and Memory clinic Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya , Barcelona, Spain Laura Morelli 162 Laboratory of Brain Aging and Neurodegeneration- FIL-CONICET , Buenos Aires, Argentina Fermín Moreno 10 CIBERNED, Network Center for Biomedical Research (...) Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer disease and highlights potential translational opportunities New insights on the genetic etiology of Alzheimer’s and related dementia | medRxiv Search for this keyword New insights on the genetic etiology of Alzheimer’s and related dementia Céline Bellenguez , Fahri Küçükali , Iris Jansen , Victor Andrade , Sonia Moreno-Grau , Najaf Amin , Adam C. Naj , Benjamin Grenier-Boley , Rafael

2020 Cold Spring Harbor Laboratory

4. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials Full Text available with Trip Pro

Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other (...) Psychiatry Actions . 2020 Jul 20;jnnp-2019-321913. doi: 10.1136/jnnp-2019-321913. Online ahead of print. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials # , # , # , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China jintai_yu

2020 EvidenceUpdates

5. Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and Mild Cognitive Impairment: A systematic review Full Text available with Trip Pro

Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and Mild Cognitive Impairment: A systematic review Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and Mild Cognitive Impairment: A systematic review | medRxiv Search for this keyword Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and Mild Cognitive Impairment: A systematic review BUHARI (...) ; For correspondence: M. Iqbal Saripan 1 Universiti Putra Malaysia; For correspondence: Subapriya Suppiah 1 Universiti Putra Malaysia; For correspondence: Abstract Resting state fMRI (rs-fMRI) detects functional connectivity (FC) abnormalities that occur in the brains of patients with Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). FC of the default mode network (DMN), which is involved in memory consolidation, is commonly impaired in AD and MCI. We aimed to determine the diagnostic power of rs-fMRI

2020 Cold Spring Harbor Laboratory

6. Machine Learning for the Classification of Alzheimer’s Disease and Its Prodromal Stage Using Brain Diffusion Tensor Imaging Data: A Systematic Review Full Text available with Trip Pro

Machine Learning for the Classification of Alzheimer’s Disease and Its Prodromal Stage Using Brain Diffusion Tensor Imaging Data: A Systematic Review Processes | Free Full-Text | Machine Learning for the Classification of Alzheimer’s Disease and Its Prodromal Stage Using Brain Diffusion Tensor Imaging Data: A Systematic Review Next Article in Journal Next Article in Special Issue Previous Article in Journal Previous Article in Special Issue Information Initiatives Notice You can make (...) section of our website. Feedback Please let us know what you think of our products and services. Information Our dedicated information section provides allows you to learn more about MDPI. JSmol Viewer Open Access Review Machine Learning for the Classification of Alzheimer’s Disease and Its Prodromal Stage Using Brain Diffusion Tensor Imaging Data: A Systematic Review by 1,* , 2 , 1 and 1 1 Institute of Clinical Physiology-National Research Council of Italy (IFC-CNR), Via Moruzzi, 1, 56124 Pisa, Italy

2020 Processes

7. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. Full Text available with Trip Pro

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. There are limitations in current diagnostic testing approaches for Alzheimer disease (AD).To examine plasma tau phosphorylated at threonine 217 (P-tau217) as a diagnostic biomarker for AD.Three cross-sectional cohorts: an Arizona-based neuropathology cohort (cohort 1), including 34 participants with AD and 47 without AD (dates of enrollment, May 2007-January 2019); the Swedish BioFINDER (...) -2 cohort (cohort 2), including cognitively unimpaired participants (n = 301) and clinically diagnosed patients with mild cognitive impairment (MCI) (n = 178), AD dementia (n = 121), and other neurodegenerative diseases (n = 99) (April 2017-September 2019); and a Colombian autosomal-dominant AD kindred (cohort 3), including 365 PSEN1 E280A mutation carriers and 257 mutation noncarriers (December 2013-February 2017).Plasma P-tau217.Primary outcome was the discriminative accuracy of plasma P-tau217

2020 JAMA

8. Effect of periodontal disease on Alzheimer’s disease: protocol of a systematic review Full Text available with Trip Pro

Effect of periodontal disease on Alzheimer’s disease: protocol of a systematic review INPLASY Protocol 631 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

9. Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial Full Text available with Trip Pro

in beta-amyloid protein–infused rats. J Neurochem. 1996;66(3):1113-1117. doi:10.1046/j.1471-4159.1996.66031113.x - - Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson’s, Alzheimer’s with parkinsonism, and Alzheimer’s disease. Mov Disord. 1997;12(6):885-897. doi:10.1002/mds.870120609 - - Pan X, Kaminga AC, Wen SW, Wu X, Acheampong K, Liu A. Dopamine and dopamine receptors (...) Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID

2020 EvidenceUpdates

10. Pharmacological and Non-Pharmacological Interventions to Enhance Sleep in Mild Cognitive Impairment and Mild Alzheimer s Disease: A Systematic Review Full Text available with Trip Pro

Pharmacological and Non-Pharmacological Interventions to Enhance Sleep in Mild Cognitive Impairment and Mild Alzheimer s Disease: A Systematic Review Pharmacological and Non-Pharmacological Interventions to Enhance Sleep in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review | medRxiv Search for this keyword Pharmacological and Non-Pharmacological Interventions to Enhance Sleep in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review Jonathan (...) Suboptimal sleep causes cognitive decline and probably accelerates Alzheimer’s Disease (AD) progression. Several sleep interventions have been tested in established AD dementia cases. However early intervention is needed in the course of AD at Mild Cognitive Impairment (MCI) or mild dementia stages to help prevent decline and maintain good quality of life. This systematic review aims to summarize evidence on sleep interventions in MCI and mild AD dementia. Seven databases were systematically searched

2020 Cold Spring Harbor Laboratory

11. Flortaucipir F18 (Tauvid) - Diagnostic agent for patients with Alzheimer’s disease

Flortaucipir F18 (Tauvid) - Diagnostic agent for patients with Alzheimer’s disease Drug Approval Package: TAUVID U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: TAUVID Company: Avid Radiopharmaceuticals, Inc. Application Number: 212123 Approval Date: 05/28/2019 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review Files (PDF

2020 FDA - Drug Approval Package

12. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Full Text available with Trip Pro

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Alzheimer's disease and its complications are the leading cause of death in adults with Down syndrome. Studies have assessed Alzheimer's disease in individuals with Down syndrome, but the natural history of biomarker changes in Down syndrome has not been established. We characterised the order and timing of changes in biomarkers of Alzheimer's disease in a population of adults with Down (...) Initiative on Neurodegeneration. We used a first-order locally estimated scatterplot smoothing curve to determine the order and age at onset of the biomarker changes, and the lowest ages at the divergence with 95% CIs are also reported where appropriate.Between Feb 1, 2013, and June 28, 2019 (Barcelona), and between June 1, 2009, and Dec 31, 2014 (Cambridge), we included 388 participants with Down syndrome (257 [66%] asymptomatic, 48 [12%] with prodromal Alzheimer's disease, and 83 [21%] with Alzheimer's

2020 Lancet

13. Reabilitação Cognitiva em Pacientes com a Doença de Alzheimer: Revisão Sistemática / Cognitive Rehabilitation in Patients with Alzheimer's Disease: Systematic Review Full Text available with Trip Pro

. JELIC, V. et al. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis. Dement Geriatr Cogn Disord, Stockholm, 26(5): 458-66, 2008. MANSUR, L. L., et al. Linguagem e cognição na doença de Alzheimer. Psicologia: reflexão e crítica, Porto Alegre, 18(3): 300-307, 2005. MARTIN, B. K., et al. Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Arch Neurol., Baltimore, 65(7): 896–905, 2008. MECOCCI, P.; BLADSTRÖM (...) (8): 1395-1400, 2011. VON BERNHARDI M., R. Mecanismos neurológicos de la enfermedad de Alzheimer. Revista Chilena de neuro-psiaquiatria. 43(2): 123-132, 2005. WILKINSON, D. et al. Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease. Dement Geriatr Cogn Disord., Bath, 28(3): 244–251, 2009. WROOLIE, T. et al. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. Acta Neurol Scand, San Diego, 119(3): 172

2020 ID on line REVISTA DE PSICOLOGIA

14. Efficacy and safety of Chinese herbal medicine in the treatment of Alzheimer's disease: a systematic review and IPD meta-analysis Full Text available with Trip Pro

Efficacy and safety of Chinese herbal medicine in the treatment of Alzheimer's disease: a systematic review and IPD meta-analysis Inplasy Protocol 335 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

15. Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women with Alzheimer's Disease Full Text available with Trip Pro

Sirota Corresponding Author DOI: License: This work is licensed under a CC BY 4.0 License. Abstract Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia in the United States. In spite of evidence of females having a greater lifetime risk of developing Alzheimer’s Disease (AD) and greater apolipoprotein E4-related (apoE4) AD risk compared to males, molecular signatures underlying these findings remain elusive. Methods: We took a meta (...) : This work is licensed under a CC BY 4.0 License. Declarations Abstract Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia in the United States. In spite of evidence of females having a greater lifetime risk of developing Alzheimer’s Disease (AD) and greater apolipoprotein E4-related (apoE4) AD risk compared to males, molecular signatures underlying these findings remain elusive. Methods: We took a meta-analysis approach to study gene

2020 Research Square

16. Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT Full Text available with Trip Pro

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need (...) . >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Minocycline did not delay the progress of cognitive or functional impairment in people with mild Alzheimer's disease over 2 years and minocycline 400 mg was poorly tolerated. {{author}} {{($index , , , , , , , , , , , , , , , , , , , & . Robert Howard 1, * , Olga Zubko 2 , Richard Gray 3 , Rosie Bradley 4 , Emma Harper 4 , Linda Kelly 4 , Lynn Pank 4 , John O’Brien 5 , Chris Fox 6 , Naji Tabet 7 , Gill

2020 NIHR HTA programme

17. Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women with Alzheimer's Disease Full Text available with Trip Pro

Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women with Alzheimer's Disease Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women with Alzheimer’s Disease | bioRxiv Search for this keyword New Results Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women with Alzheimer’s Disease Manish D Paranjpe , Stella Belonwu , Jason K Wang , Tomiko Oskotsky , Aarzu Gupta , Alice Taubes , Kelly Zalokusky , Ishan Paranjpe (...) , Benjamin S Glicksberg , Yadong Huang , Marina Sirota , for the Alzheimer’s Disease Neuroimaging Initiative doi: https://doi.org/10.1101/2020.04.24.060558 Manish D Paranjpe 1 UCSF Bakar Computational Health Sciences Institute, University of California San Francisco , San Francisco, CA, USA 2 Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School , Boston, MA, USA Stella Belonwu 1 UCSF Bakar Computational Health Sciences Institute, University of California San Francisco , San

2020 Cold Spring Harbor Laboratory

18. Acupuncture therapy for Alzheimer’s disease: A protocol for an overview of systematic reviews Full Text available with Trip Pro

Acupuncture therapy for Alzheimer’s disease: A protocol for an overview of systematic reviews Inplasy Protocol 57 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment. (Abstract)

Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment. Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic predementia phase of Alzheimer's disease dementia, characterised by cognitive and functional impairment not severe enough to fulfil the criteria for dementia. In clinical samples, people with amnestic MCI are at high risk of developing Alzheimer's disease dementia, with annual (...) rates of progression from MCI to Alzheimer's disease estimated at approximately 10% to 15% compared with the base incidence rates of Alzheimer's disease dementia of 1% to 2% per year.To assess the diagnostic accuracy of structural magnetic resonance imaging (MRI) for the early diagnosis of dementia due to Alzheimer's disease in people with MCI versus the clinical follow-up diagnosis of Alzheimer's disease dementia as a reference standard (delayed verification). To investigate sources

2020 Cochrane